دورية أكاديمية
Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial
العنوان: | Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial |
---|---|
المؤلفون: | Kilic, Sinem, van't Hof, Arnoud W.J., ten Berg, Jurrien, Lopez, Ana Ayesta, Zeymer, Uwe, Hamon, Martial, Soulat, Louis, Bernstein, Debra, Deliargyris, Efthymios N., Steg, Phillippe Gabriel |
المصدر: | In International Journal of Cardiology 15 May 2016 211:119-123 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!